Study Finds Extensive Use of Opioids and Benzodiazepines in Extremely Preterm Infants in NICUs

A recent study published in the *Journal of Perinatology* has revealed significant findings regarding the exposure of extremely preterm neonates to opioids and benzodiazepines in neonatal intensive care units (NICUs). The research highlights the extent of pharmacologic interventions administered to this vulnerable population, shedding light on the cumulative use of these medications during critical stages of development.

The study focuses on extremely preterm infants, who often require intensive medical care due to their underdeveloped organs and systems. Researchers analyzed data related to opioid and benzodiazepine administration, aiming to quantify exposure levels and understand patterns of usage. The findings emphasize the widespread use of these drugs in NICUs, raising questions about their potential long-term effects on neurodevelopmental outcomes. This research underscores a growing need for further investigation into the implications of such treatments for preterm neonates.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

Related posts:

Generic Drug Market to Reach $250 Billion by 2025: Companies Emphasize First-to-File, Quality, and Partnerships Pharma and Med Devices Conclave 2025 Explores Just-in-Time Delivery Strategies in Mumbai Study Finds GLP-1 Receptor Agonists Safe for Overweight Patients to Reduce Surgical Risks Trump Administration Partners with EMD Serono to Lower Fertility Drug Costs and Expand IVF Access

Author

GOAI